Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3032185	p-jcvnh	— (—)	127	759	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications: immunosuppressive drugs

108

83.82

190.99

6.8

1.0

—

Renal failure

82.52

156.95

7.4

1.6

—

Azathioprine

67.41

146.20

7.5

5.5

—

All chronic kidney diseases

50.23

143.52

7.4

1.2

—

Hypoplasia of dental enamel

72.93

124.90

7.9

6.6

—

Second line medication for Crohn's disease

27.72

122.75

7.3

3.4

—

Molar incisor enamel hypoplasia

46.27

119.90

7.9

8.0

—

L04AX Other immunosuppressants

26.51

119.41

7.3

3.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

110

51.34

116.00

6.7

1.0

—

Hypoplasia of dental enamel , including avohilmo

42.77

115.17

7.8

8.2

—

ILD medications

111

50.21

113.49

6.7

1.0

—

First line medication for Crohn's disease

111

50.05

113.12

6.7

1.0

—

All kidney diseases

101

27.64

111.72

7.2

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

35.13

109.27

7.0

1.2

—

Glomerular diseases

40.97

100.80

7.1

6.1

—

Renal tubulo-interstitial diseases

22.62

97.86

7.1

3.3

—

L04AD Calcineurin inhibitors

100

204.41

96.78

7.3

2.4

—

Glomerulonephritis

53.67

92.78

7.5

8.2

—

Chronic kidney disease

177.55

85.58

7.6

1.8

—

Diarrhoea and gastroenteritis of presumed infectious origin

18.83

84.17

7.2

4.0

—

Antihypertensive medication - note that there are other indications

24.16

79.22

7.2

2.4

—

Fever of other and unknown origin

29.89

79.05

5.6

4.6

—

Hypertensive diseases (excluding secondary)

27.05

76.26

7.5

3.8

—

Other problems related to primary support group, including family circumstances

23.06

73.04

8.3

7.4

—

Viral and other specified intestinal infections

23.80

70.06

7.8

4.1

—

L04AA Selective immunosuppressants

97.01

69.94

6.9

3.6

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

16.62

67.63

7.9

6.0

—

Inflammatory bowel disease treatment related agents

14.49

67.19

7.0

3.4

—

Cardiovascular diseases (excluding rheumatic etc)

16.66

66.73

7.1

4.9

—

Viral and other specified intestinal infections

20.12

66.29

7.7

4.1

—

Hypertensive diseases

17.17

64.93

7.5

2.9

—

Hypertension

17.17

64.91

7.5

2.9

—

Intestinal infectious diseases

13.63

63.80

6.9

3.6

—

Persons encountering health services for specific procedures and health care

12.97

61.01

6.6

4.2

—

Genitourinary diseases

27.43

60.93

8.1

1.2

—

Viral infections characterized by skin and mucous membrane lesions

12.36

58.82

6.2

6.4

—

Acute tubulo-interstitial nephritis

19.63

58.52

7.2

3.5

—

Cardiovascular diseases

14.42

55.57

7.1

4.7

—

Excessive attrition of teeth

12.06

52.99

7.8

3.9

—

Dependence on enabling machines and devices, not elsewhere classified

+∞

50.97

7.5

0.0

—

Molar incisor enamel hypoplasia, with caries

75.72

50.17

7.9

7.7

—

Any gastric operation

28.11

48.34

6.5

2.6

—

GASTRO-related operations

28.11

48.34

6.5

2.6

—

Gingival hyperplasia

78.87

47.29

8.4

7.1

—

Septicaemia

13.47

47.25

7.3

5.9

—

Nephrotic syndrome

74.31

44.33

7.6

10.0

—

Explicit Sepsis

11.95

44.02

7.3

5.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

10.81

43.50

6.4

3.7

—

Other septicaemia

13.17

42.22

7.0

5.6

—

Viral infections characterized by skin and mucous membrane lesions

8.14

41.42

5.9

—

Other bacterial diseases

8.55

39.23

6.9

5.1

—

Congenital malformations of the urinary system

14.79

39.11

8.1

7.0

—

Congenital malformations of the urinary system

14.77

39.10

8.1

7.0

—

Other dialysis

89.41

39.06

8.2

7.2

—

Certain infectious and parasitic diseases

21.86

38.88

5.6

2.6

—

Extracorporeal dialysis

71.10

37.03

6.7

7.2

—

Anomalies of dental arch relationship, including avohilmo

13.02

35.47

7.6

6.2

—

Other bacterial diseases

7.57

35.43

6.9

5.1

—

Erosion of teeth , including avohilmo

12.10

34.99

7.3

4.5

—

Dental caries

56.46

34.51

7.0

1.6

—

Acute upper respiratory infections of multiple and unspecified sites

10.52

34.24

6.4

3.0

—

All influenza

12.25

33.22

6.5

6.8

—

Other viral diseases

7.62

32.75

7.7

6.0

—

Other viral diseases

7.85

32.18

7.9

6.3

—

Other viral diseases, not elsewhere classified

7.90

30.84

7.5

6.7

—

11.56

30.48

5.8

2.5

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

11.56

30.48

5.8

2.5

—

Crowding of teeth, including avohilmo

9.26

30.29

7.1

8.0

—

Other viral diseases, not elsewhere classified

8.31

29.84

7.7

6.9

—

Influenza and pneumonia

6.26

29.48

6.4

5.4

—

Intestinal infectious diseases

8.09

28.89

5.8

3.7

—

Bacterial infection, other or unspecified

11.02

28.84

5.0

4.9

—

Acute suppurative otitis media

9.93

28.82

7.4

5.6

—

Congenital malformations, deformations and chromosomal abnormalities

7.19

28.64

6.3

5.6

—

Otitis media, unspecified

11.03

27.93

6.1

6.7

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6.11

27.02

5.8

6.4

—

Disorders of other endocrine glands

6.78

26.91

7.7

6.3

—

Viral warts

10.77

26.86

6.7

6.2

—

Aplastic and other anaemias

11.27

26.70

5.4

5.2

—

Bacterial infection, other or unspecified

9.97

26.67

5.0

5.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

7.09

26.46

8.1

7.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

7.08

26.41

8.1

7.0

—

General symptoms and signs

11.08

26.36

4.4

4.2

—

Nonsuppurative otitis media

9.54

26.18

5.5

5.9

—

Suppurative and unspecified otitis media

9.15

25.74

6.9

5.6

—

Other disorders of kidney and ureter

44.49

25.49

7.4

6.6

—

Congenital malformations, deformations and chromosomal abnormalities

6.63

25.08

6.6

5.5

—

Disorders resulting from impaired renal tubular function

59.20

25.07

7.5

5.6

—

Anaemias

33.65

24.49

6.5

7.7

—

Gastrointestinal diseases

38.12

24.00

6.2

1.6

—

General examination and investigation of persons without complaint and reported diagnosis

14.36

23.94

6.8

1.5

—

Bronchitis

8.19

23.55

5.1

2.6

—

Other reaction to severe stress, and adjustment disorders

9.34

23.50

4.7

4.4

—

Diseases of middle ear and mastoid

7.74

23.18

5.4

5.0

—

Caries of dentine

45.48

22.98

5.6

1.7

—

Codes for special purposes

7.33

22.80

5.6

5.2

—

Provisional assignment of new diseases of uncertain etiology

7.33

22.80

5.6

5.2

—

Care involving use of rehabilitation procedures

8.61

22.01

6.3

4.7

—

Pneumonia, organism unspecified

5.76

22.00

6.6

5.7

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

5.75

21.94

7.2

6.4

—

Nausea and vomiting

7.14

21.44

7.9

7.1

—

Examination and observation for other reasons

14.21

20.95

6.4

1.1

—

Bacterial Sepsis

9.67

20.68

5.8

5.0

—

Viral warts

22.63

19.03

7.0

7.1

—

Hypoplasia of dental enamel, prenatal , including avohilmo

34.69

18.93

8.8

10.6

—

Pneumonias (Asthma/COPD co-morbidities)

4.70

18.74

6.4

5.7

—

Deep bite

6.06

18.17

7.4

8.0

—

All pneumoniae

4.49

17.77

6.4

5.8

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4.48

17.54

6.5

5.8

—

Acute upper respiratory infections

6.35

16.75

6.0

2.9

—

Disorders of refraction and accommodation

5.62

16.67

7.8

7.1

—

Implicit Sepsis

6.15

16.33

5.2

4.9

—

Condition for Implicit Sepsis (Organ dysfunction codes)

5.82

16.05

5.2

4.7

—

Implicit viral Sepsis

18.50

15.97

5.9

6.3

—

Viral Sepsis

18.50

15.97

5.9

6.3

—

Certain conditions originating in the perinatal period

6.02

15.94

8.9

6.1

—

Implicit Sepsis

5.85

15.87

5.3

4.7

—

COPD/asthma/ILD related infections

7.28

15.70

5.5

2.5

—

COPD/asthma related infections

7.28

15.70

5.5

2.5

—

Other special examinations and investigations of persons without complaint or reported diagnosis

10.55

15.44

6.6

1.5

—

Caries of enamel

5.33

15.34

7.2

3.8

—

5.43

15.06

8.3

8.0

—

6.32

14.81

5.3

2.6

—

Anxiety disorders, excluding more controls

5.93

14.80

5.8

4.0

—

Other endocrine disorders

6.20

14.53

9.5

7.8

—

Condition for Implicit Sepsis (Organ dysfunction codes)

5.17

14.18

5.2

4.7

—

Implicit viral Sepsis

11.92

14.03

5.7

—

Symptoms and signs concerning food and fluid intake

23.78

13.75

8.1

4.9

—

Dentofacial anomalies [including malocclusion]

5.71

13.62

7.4

3.6

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4.31

13.43

6.1

5.4

—

Lack of expected normal physiological development

19.80

13.25

7.6

6.7

—

Certain infectious and parasitic diseases

15.66

12.93

6.1

2.6

—

5.17

12.92

8.3

8.0

—

Other disorders of urethra and urinary system

5.41

12.40

7.7

4.3

—

Disorders of psychological development

4.65

12.38

8.2

7.5

—

Covid-19 confirmed case

8.94

12.19

5.6

4.5

—

Crossbite

4.74

12.16

8.4

7.4

—

Neurotic, stress-related and somatoform disorders

4.33

12.11

5.9

4.5

—

Anxiety disorders

4.31

12.04

5.9

4.5

—

Medical observation and evaluation for suspected diseases and conditions

8.95

11.93

5.2

1.5

—

Persons encountering health services in other circumstances, wide

3.98

11.73

6.3

5.4

—

All influenza (not pneumonia)

12.53

11.60

6.3

7.8

—

Headache

10.21

11.51

4.8

4.1

—

Speech and linguistic disorders, excluding more controls

8.73

11.44

8.7

7.4

—

Endocrine, nutritional and metabolic diseases

3.92

11.43

6.6

5.4

—

Tonsillectomy and adenotomy

3.78

11.43

6.7

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.13

11.30

7.8

6.4

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

20.38

11.16

8.9

8.8

—

Other disorders starting during childhood or adolecense, excluding more controls

8.88

11.13

7.7

7.6

—

Convulsions, not elsewhere classified

13.69

10.86

5.3

5.5

—

Other acute lower respiratory infections

4.03

10.85

6.4

6.3

—

Other disorders of fluid, electrolyte and acid-base balance

12.07

10.77

7.4

4.1

—

Short stature, not elsewhere classified

5.36

10.37

8.3

7.7

—

Implicit bacterial Sepsis

11.23

10.28

5.0

4.2

—

Heart failure, not strict

4.77

10.26

4.8

5.2

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.64

9.97

7.7

7.5

—

Implicit bacterial Sepsis

10.26

9.81

5.0

4.1

—

Zoster [herpes zoster]

26.03

9.80

2.7

5.6

—

Hypermetropia

7.82

9.60

7.9

8.9

—

Diseases of external ear

4.88

9.29

8.3

6.9

—

Acute bronchiolitis

4.27

9.16

7.0

8.2

—

Metabolic disorders

3.66

9.14

6.8

5.6

—

Infections, IBD-co-morbidities

14.30

9.13

5.4

8.3

—

Dermatitis

4.45

8.76

7.0

4.5

—

Unspecified haematuria

10.07

8.68

4.5

6.5

—

Speech and linguistic disorders

3.89

8.65

8.7

7.4

—

Other disorders starting during childhood or adolescence

4.10

8.58

7.7

8.1

—

Other congenital malformations of the digestive system

4.76

8.51

6.5

9.2

—

Diseases of the ear and mastoid process

3.74

8.46

5.4

3.9

—

Other and unspecified dermatitis

4.64

8.33

7.4

4.7

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

11.76

8.08

9.5

9.8

—

Overjet

4.78

8.07

7.4

8.1

—

Other diseases of hard tissues of teeth

10.99

7.98

8.5

1.5

—

Otitis externa

6.56

7.86

8.4

8.1

—

Other and unspecified anaemias

7.15

7.83

4.6

5.2

—

Other anaemias

7.13

7.82

4.6

5.2

—

Symptoms and signs involving the digestive system and abdomen

3.14

7.73

6.3

6.0

—

Zoster [herpes zoster]

8.29

7.70

3.2

3.3

—

Other and unspecified tonsillitis

6.66

7.70

6.9

3.6

—

Hernia

3.35

7.63

7.0

5.4

—

Symptoms and signs involving the urinary system

3.81

7.60

5.5

6.1

—

Other bacterial intestinal infections

18.35

7.59

3.5

4.7

—

Other heart diseases

4.77

7.42

7.4

4.7

—

Other congenital malformations of the digestive system

4.22

7.39

6.5

9.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

7.63

7.37

2.4

8.9

—

Other cataract

9.46

7.36

7.7

3.9

—

Congenital vesicoureteral reflux

16.36

7.30

8.5

6.9

—

Excessive, frequent and irregular menstruation

9.74

7.29

3.8

4.2

—

Exclusions for E4_PCOS_BROAD

3.93

7.14

6.8

8.2

—

Other diseases of urinary system

3.09

7.04

7.3

5.5

—

Otitis externa, unspecified

8.77

7.04

8.1

7.6

—

Acute pharyngitis

8.69

6.99

6.8

4.6

—

Other medical care

8.99

6.99

2.4

3.2

—

Non-Hodgkin lymphoma, all, including Hilmo

16.70

6.74

1.9

6.3

—

Other strabismus

3.99

6.57

7.1

7.4

—

Distal bite

4.01

6.56

7.4

8.1

—

Diseases of the eye and adnexa

3.11

6.42

5.8

6.2

—

Acute sinusitis

6.17

6.38

3.6

2.7

—

Inguinal hernia

3.79

6.37

7.4

5.5

—

Tooth eruption problems

3.62

6.36

7.0

6.3

—

Bacterial intestinal infections, IBD co-morbidities

11.01

6.29

3.5

6.5

—

Tubulo-interstitial nephritis, not specified as acute or chronic

+∞

6.25

6.5

0.0

—

Other pulmonary diagnosis

6.55

6.12

4.6

1.7

—

Excluding asthma or asthma-COPD overlap

6.55

6.12

4.6

1.7

—

COPD differential diagnosis

6.55

6.12

4.6

1.7

—

ILD differential diagnosis

6.55

6.12

4.6

1.7

—

Bacterial pneumoniae

5.88

6.12

4.2

4.6

—

Complications of surgical and medical care, not elsewhere classified

3.23

6.11

5.1

4.8

—

Any mental disorder

3.19

6.04

5.9

4.8

—

Bacterial pneumonia (organism specified)

3.95

5.99

4.3

4.9

—

Hernia of abdominal wall

6.00

5.98

6.5

4.5

—

Asthma (only as main-diagnosis), excluding more controls

7.15

5.95

4.1

1.8

—

Hyperkinetic disorders, excluding more controls

5.99

5.93

9.3

6.5

—

Melanocytic naevi of trunk

15.02

5.90

8.9

5.0

—

Chronic diseases of tonsils and adenoids

2.73

5.83

6.2

6.5

—

Asthma (only as main-diagnosis)

6.68

5.74

4.1

1.7

—

Other diseases of blood and blood-forming organs, wide

6.85

5.72

6.5

6.3

—

Persons with potential health hazards related to communicable diseases

2.98

5.69

7.7

6.5

—

Varicella [chickenpox]

12.91

5.58

4.9

9.0

—

Invasive ventilation

12.89

5.58

12.1

7.6

—

Agranulocytosis

12.88

5.58

7.9

6.3

—

Liquid cancers, helper endpoint

5.17

5.57

2.4

7.4

—

Certain disorders involving the immune mechanism

6.51

5.54

4.8

7.3

—

Covid-19 suspected case

6.51

5.54

5.9

5.0

—

Asthma, excluding more controls

6.52

5.51

4.1

1.8

—

Cough

3.39

5.49

6.5

5.9

—

Oxycodone

10.05

5.42

1.7

1.6

—

Non-allergic asthma (mode)

15.86

5.38

6.6

2.6

—

Respiratory and cardiovascular disorders specific to the perinatal period

3.18

5.33

9.7

7.8

—

Umbilical hernia

9.10

5.28

7.2

3.8

—

Asthma

6.05

5.27

4.1

1.7

—

Strabismus

3.27

5.27

6.7

7.7

—

Bacterial pneumonia, not elsewhere classified

5.61

5.25

4.3

4.5

—

Other demyelinating diseases of the central nervous system

+∞

5.21

1.0

0.0

—

MS-disease / Multiple Sclerosis

+∞

5.21

1.0

0.0

—

Emotional disorders starting during childhood or adolecense, excluding more controls

6.53

5.15

4.9

7.4

—

Neoplasms

2.57

5.13

6.1

6.7

—

Autoimmune diseases related-to ILD

2.99

5.09

3.9

5.5

—

Immunodeficiencies

13.38

5.08

6.0

7.2

—

Delayed milestone in childhood

3.28

5.08

7.7

8.8

—

Enlarged lymph nodes

13.34

5.07

2.5

5.0

—

Melanocytic naevi

5.19

5.07

8.3

5.0

—

Noninflammatory disorders of female genital tract

6.39

5.07

4.5

4.6

—

Diseases of the respiratory system

5.78

5.06

5.1

1.7

—

Used for control exclusion in common control thyroid runs

2.40

4.95

4.9

6.6

—

Childhood asthma (age<16)

8.76

4.94

5.7

1.9

—

Childhood asthma (age<16), excluding more controls

8.76

4.94

5.7

1.9

—

Irregular menses

5.70

4.88

3.6

3.1

—

Motor disorders, excluding more controls

6.07

4.87

7.8

8.7

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

4.49

4.78

9.5

8.6

—

Need for other prophylactic measures

9.03

4.78

9.1

8.5

—

Symptoms and signs involving the skin and subcutaneous tissue

2.97

4.74

4.2

6.2

—

Congenital malformations and deformations of the musculoskeletal system

3.15

4.71

6.9

8.2

—

Neurological diseases, wide definition

4.02

4.70

6.6

7.3

—

All anxiety disorders

3.13

4.66

5.9

4.7

—

Open bite

4.31

4.62

7.9

8.0

—

Systemic connective tissue disorders

6.11

4.59

3.2

5.3

—

Psychiatric diseases

2.85

4.59

6.3

4.8

—

Disorders of lens

4.68

4.58

7.7

2.9

—

Hypokalaemia

14.02

4.57

8.3

6.0

—

Congenital malformations and deformations of the musculoskeletal system

3.20

4.56

6.9

8.5

—

Other anxiety disorders

3.51

4.48

3.9

4.2

—

Contraceptive management

5.07

4.39

3.8

1.6

—

Herpesviral [herpes simplex] infections

7.51

4.35

5.8

3.7

—

Malaise and fatigue

5.90

4.33

2.8

4.9

—

Asthma (mode)

5.35

4.31

3.9

1.7

—

Other disorders of adrenal gland

8.92

4.28

5.8

6.4

—

Volume depletion

8.90

4.27

7.6

5.7

—

Explicit bacterial Sepsis

11.68

4.27

8.1

9.0

—

Dysphagia

11.67

4.27

3.6

7.5

—

Acute laryngitis and tracheitis

6.16

4.23

9.2

4.8

—

Infections of the skin and subcutaneous tissue

2.56

4.20

6.3

6.0

—

Acute bronchitis

3.14

4.18

7.0

6.9

—

Abdominal and pelvic pain

2.47

4.16

6.3

6.0

—

Hypothyroidism (congenital or acquired)

8.48

4.08

3.3

7.7

—

2.57

4.06

5.7

6.7

—

Amblyopia ex anopsia

4.64

4.06

6.4

8.7

—

Tooth agenesis EXCLUDE clefts and syndromes

4.64

4.05

6.6

7.1

—

Pain, not elsewhere classified

8.00

4.05

4.6

3.6

—

Visual disturbances and blindness

2.86

4.05

5.0

6.5

—

Varicella [chickenpox]

6.44

3.98

4.9

9.6

—

Heart failure and antihypertensive medication

7.36

3.95

4.9

1.0

—

Asthma, unspecified (mode), excluding more controls

6.73

3.87

5.4

1.9

—

Mycoses

4.79

3.86

6.5

6.1

—

Speech therapy

6.00

3.81

5.0

6.2

—

Other diseases of lip and oral mucosa

4.29

3.81

6.1

4.8

—

Specific development disorders of speech and language

3.08

3.79

10.7

7.6

—

Disturbance of activity and attention

3.07

3.78

9.3

7.0

—

Persons encountering health services for examination and investigation

5.01

3.78

5.9

1.5

—

Disorders of skin appendages

2.83

3.77

7.0

4.8

—

Haemolytic anaemias

12.04

3.76

8.5

7.6

—

Streptococcal septicaemia

12.02

3.76

9.3

9.6

—

Oedema, not elsewhere classified

8.63

3.73

6.9

3.7

—

Gingivitis and periodontal diseases

2.44

3.70

5.3

5.7

—

Dental caries, including avohilmo

3.27

3.69

8.6

5.1

—

Mandibular retrognathia

4.14

3.69

7.3

7.8

—

Asthma, unspecified (mode)

6.16

3.68

5.4

1.8

—

Symptoms and signs involving the circulatory and respiratory systems

2.31

3.65

6.6

5.3

—

Asthma, hospital admission 2, infections

2.42

3.62

5.7

6.5

—

Asthma-related infections

2.42

3.62

5.7

6.5

—

Hypopituitarism

4.01

3.59

8.1

7.7

—

Polycystic ovarian syndrome, consortium definition

4.05

3.56

3.6

3.1

—

Perforation of tympanic membrane

7.79

3.55

6.0

7.8

—

Candidiasis

7.78

3.55

4.4

8.2

—

Inflammatory diseases of the central nervous system

10.01

3.49

6.3

5.8

—

Complications of medical and surgical care

2.93

3.49

6.1

4.5

—

Diseases of the skin and subcutaneous tissue

2.37

3.48

6.2

4.7

—

Hypothyroidism and >3 levothyroxin purchases

7.54

3.48

3.0

7.7

—

Hypothyroidism, levothyroxine purchases

7.54

3.48

3.0

7.7

—

Diseases of the musculoskeletal system and connective tissue

2.21

3.47

5.9

7.4

—

Other disorders of skin and subcutaneous tissue

2.90

3.39

5.3

5.2

—

Specific development disorders of scholastic skills

3.48

3.35

5.2

7.5

—

Visual disturbances

2.71

3.31

5.1

6.5

—

Astigmatism

4.35

3.30

10.1

8.7

—

Hypertensive heart and/or renal disease

7.47

3.29

4.9

2.3

—

Bacterial, viral and other infectious agents

8.58

3.26

6.2

8.6

—

Diseases of oral cavity, salivary glands and jaws

5.79

3.26

7.1

1.5

—

Gout, FINNGEN

8.55

3.25

3.8

1.6

—

Diseases of pulp and periapical tissues and dental caries

3.07

3.18

9.1

5.1

—

Heart failure,strict

4.41

3.16

4.5

4.9

—

Heart failure, strict

4.41

3.16

4.5

4.9

—

Continuous positive airway pressure

4.21

3.14

10.5

7.9

—

Recurrent aphthous stomatitis , including avohilmo

4.50

3.11

5.0

6.5

—

Anxiety (asthma-related co-morbidities)

2.45

3.08

5.9

5.0

—

Intermittent heterotropia

3.67

3.08

7.5

8.5

—

Rash and other nonspecific skin eruption

7.51

3.05

6.7

10.0

—

Iron deficiency anaemia

3.38

3.04

8.7

5.5

—

Benign neoplasms

2.22

3.03

6.4

4.8

—

Embedded and impacted teeth

2.55

3.03

7.2

5.5

—

Anterior Iridocyclitis

5.84

3.02

1.6

4.9

—

Nutritional anaemias

3.13

2.99

8.5

5.0

—

Gout

7.54

2.99

3.8

1.6

—

Other diseases of intestine

10.01

2.98

1.6

5.0

—

Ventral hernia

10.00

2.98

5.6

2.4

—

Other CVD

10.00

2.98

4.2

5.4

—

Pulmonary embolism

10.00

2.98

2.6

1.8

—

Pulmonary heart disease

10.00

2.98

2.6

1.8

—

Hypertensive Heart Disease

7.83

2.98

4.7

2.5

—

Opioids

2.77

2.91

2.4

2.9

—

Unspecified acute lower respiratory infection

4.71

2.91

3.9

5.7

—

Sequelae of external causes of morbidity and mortality

4.71

2.91

3.8

4.9

—

Asthma-related pneumonia

2.69

2.87

5.7

7.1

—

Congenital deformities of feet

6.70

2.87

4.8

7.9

—

Congenital deformities of feet

5.40

2.87

5.1

7.3

—

Bacterial, viral and other infectious agents

6.67

2.86

6.2

8.8

—

Specific developmental disorder of motor function

3.21

2.86

7.8

8.4

—

Sequelae with surgical and medical care as external cause

6.67

2.86

4.7

5.7

—

Pulmonary heart disease, diseases of pulmonary circulation

6.67

2.86

2.3

4.9

—

Other noninfective gastroenteritis and colitis

2.77

2.80

7.9

7.7

—

Asthma-related pneumonia or sepsis

2.64

2.77

5.7

7.2

—

Asthma, hospital admissions 3, pneumonia

2.64

2.77

5.7

7.2

—

Diagnoses used for exclusion with ILD

8.34

2.75

5.2

4.3

—

Disturbances of skin sensation

5.00

2.72

3.3

—

Emotional disorders and disorders of social functioning with onset specific to childhood

3.03

2.71

4.9

7.5

—

Impacted cerumen

6.01

2.70

9.5

9.6

—

Urticaria

2.59

2.69

6.7

6.8

—

Motor disorders

3.02

2.68

7.7

9.4

—

Acne

3.45

2.68

8.3

5.4

—

Non-ischemic cardiomyopathy

5.12

2.67

5.7

5.5

—

Stomatitis and related lesions

3.75

2.67

5.0

6.2

—

All-cause Heart Failure

3.97

2.66

4.7

4.9

—

Bleeding

2.29

2.65

5.0

6.2

—

Disorders of sclera, cornea, iris and ciliary body

2.79

2.64

2.1

4.9

—

Impacted teeth

2.60

2.64

7.7

5.7

—

Urticaria and erythema

2.46

2.61

6.3

7.1

—

Oral corticosteroids

2.86

2.61

2.4

2.9

—

Procreative management

2.27

2.57

7.1

7.4

—

Pneumonia derived septicemia

7.16

2.55

9.6

9.1

—

Statin medication

2.71

2.55

4.2

3.4

—

Congenital malformations of the circulatory system

2.29

2.54

7.6

7.9

—

Conductive hearing loss, unspecified

5.46

2.54

5.8

7.3

—

Other metabolic disorders

5.46

2.54

7.3

5.4

—

Mental retardation, excluding more controls

3.90

2.49

7.4

8.6

—

Other diseases of the digestive system

3.46

2.47

5.8

6.3

—

GI-bleeding

3.46

2.47

5.8

6.3

—

Diseases of the digestive system

2.54

2.41

4.3

5.8

—

Autoimmune diseases

1.88

2.41

4.1

6.7

—

Pain and other conditions associated with female genital organs and menstrual cycle

6.57

2.40

3.2

3.4

—

Paralytic ileus and intestinal obstruction

6.25

2.37

1.6

5.5

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.21

2.36

3.0

6.9

—

Iridocyclitis

4.12

2.36

1.6

5.1

—

Conductive and sensorineural hearing loss

2.35

2.34

7.6

5.0

—

Abnormalities of breathing

2.06

2.32

5.1

5.4

—

Emotional disorders starting during childhood or adolescence

2.59

2.31

4.9

8.3

—

Malnutrition

4.64

2.27

7.5

9.8

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.90

2.26

3.9

6.8

—

Other neurological diseases

2.62

2.26

3.2

4.8

—

Congenital malformations of heart and great arteries

2.22

2.24

8.0

—

Autoimmune diseases excluding thyroid diseases

1.89

2.24

3.9

6.8

—

Open wound of wrist and hand

0.00

2.23

0.0

5.1

—

Congenital stenosis of pulmonary valve

5.64

2.22

10.8

8.6

—

Other skin changes

5.56

2.21

3.2

6.8

—

Respiratory distress of newborn

2.56

2.21

8.2

8.0

—

Persons encountering health services in circumstances related to reproduction

1.92

2.21

5.9

6.6

—

DVT of lower extremities and pulmonary embolism

5.53

2.20

2.6

1.4

—

Cystitis

2.18

2.20

6.3

4.9

—

Other heart diseases, wide

1.87

2.16

6.9

5.6

—

Diseases of pulp and periapical tissues, including avohilmo

0.38

2.15

2.6

6.1

—

Cerebrovascular diseases (FINNGEN)

5.90

2.15

4.4

1.7

—

Mild mental retardation

4.30

2.15

7.3

7.0

—

Other disorders of bone

4.29

2.15

6.8

4.6

—

Hyperkinetic disorders

2.23

2.13

9.3

7.3

—

Dermatitis and eczema

1.85

2.11

5.6

5.4

—

Other diseases of upper respiratory tract

1.85

2.10

5.7

6.4

—

Conotruncal defects

3.23

2.10

8.3

8.2

—

Congenital malformations of pulmonary and tricuspid valves

4.06

2.05

9.2

8.8

—

Other disorders of ear

1.96

2.04

7.4

5.7

—

Slow fetal growth and fetal malnutrition

4.05

2.03

6.3

8.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.67

2.03

6.3

4.5

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.40

2.02

7.7

7.4

—

Mouth breathing

2.10

2.01

8.6

6.6

—

Sensorineural hearing loss

2.38

1.99

7.8

4.5

—

Sleep disorders (combined)

0.34

1.99

6.2

5.0

—

STROKE

3.20

1.98

1.9

4.1

—

Isolated growth hormone deficiency

3.40

1.98

7.4

9.9

—

Cardiovascular disorders originating in the perinatal period

4.66

1.95

8.0

8.6

—

Viral pneumonia

4.55

1.94

6.0

6.1

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

3.77

1.94

4.3

7.1

—

Hyperlipidaemia, other/unspecified

4.60

1.93

3.0

1.4

—

Coagulation defects, purpura and other haemorrhagic conditions

2.96

1.93

8.1

7.7

—

Chronic periodontitis, complicated

3.72

1.91

2.2

1.8

—

Pain (limb, back, neck, head abdominally)

1.89

1.90

5.3

7.1

—

Fitting and adjustment of other devices

4.51

1.90

5.4

2.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3.40

1.87

2.3

2.9

—

Scissor bite

2.55

1.84

8.9

7.6

—

Congenital malformations of the respiratory system

3.55

1.84

5.2

9.5

—

Congenital malformations of the respiratory system

3.55

1.84

5.2

9.5

—

Ovarian cyst

4.81

1.83

1.6

2.7

—

Excessive earwax

2.19

1.80

8.4

5.8

—

Malignant neoplasm

2.01

1.74

2.6

6.7

—

Noninfective enteritis and colitis

2.02

1.74

7.0

6.5

—

Cellulitis

2.50

1.73

7.3

6.5

—

Acne vulgaris

2.92

1.72

8.4

5.2

—

Fall on and from stairs and steps

2.92

1.72

5.0

5.1

—

Candidiasis

2.92

1.72

4.4

5.5

—

Chondropathies

3.85

1.71

7.0

5.2

—

Cardiomyopathy

3.85

1.71

4.8

7.2

—

Intestinal stricture

3.85

1.71

1.6

5.8

—

Mixed specific developmental disorders

2.32

1.71

7.5

8.0

—

Mood disorders, excluding more controls

2.31

1.69

2.8

3.0

—

Missing teeth due to accident, extraction or parodontitis

2.87

1.68

3.0

3.3

—

Right ventricular outflow tract obstruction

3.20

1.67

9.2

8.0

—

Fracture of femur

3.78

1.67

4.4

6.3

—

Other disorders originating in the perinatal period

2.61

1.67

8.1

8.3

—

Phobic anxiety disorders

3.16

1.66

5.2

4.6

—

Disorders of puberty, all

2.82

1.65

5.1

6.9

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.98

1.64

2.3

4.8

—

Disorders of speech understanding and production

2.40

1.62

11.9

8.0

—

Other diseases of pleura

2.79

1.61

3.4

5.2

—

Disorders of optic nerve and visual pathways

3.57

1.61

3.6

7.2

—

Other and unspecified local infections of skin and subcutaneous tissue

3.57

1.61

3.0

6.6

—

Other local infections of skin and subcutaneous tissue

3.57

1.61

3.0

6.6

—

Cerebral palsy and other paralytic syndromes

3.57

1.61

5.0

6.6

—

Dental operations

3.42

1.61

7.3

1.0

—

Other and unspecified iron deficiency

2.50

1.59

11.3

5.9

—

Tramadol

2.87

1.58

1.9

2.1

—

Noninfectious colitis NAS

3.00

1.58

4.0

7.2

—

Malignant neoplasm, wide definition for exclusion

1.88

1.57

2.5

6.7

—

Venous thromboembolism

3.45

1.56

2.6

1.6

—

Non-invasive ventilation

2.98

1.54

7.2

5.1

—

Other diseases of intestines

1.65

1.54

4.2

6.7

—

Disorders in reading

3.35

1.52

4.6

8.1

—

Panic disorder

3.33

1.52

3.4

3.3

—

Asthma, hospital admissions , main diagnosis only

101

1.75

1.51

5.3

6.0

—

Fracture of skull and facial bones

2.86

1.50

7.7

6.1

—

Pain in limb

1.76

1.48

4.4

6.1

—

Injuries to the wrist and hand

108

0.45

1.47

2.1

6.0

—

Congenital malformations of eye, ear, face and neck

2.50

1.45

4.4

9.4

—

Cardiac murmurs and other cardiac sounds

2.34

1.44

12.6

6.7

—

Disorders of puberty

3.14

1.44

5.6

6.0

—

Dizziness and giddiness

2.13

1.40

1.9

4.6

—

Atopic dermatitis, strict definition with reimbursement

1.90

1.40

6.7

6.4

—

Persons encountering health services in other circumstances

2.18

1.36

6.6

5.3

—

Injuries to the knee and lower leg

100

0.50

1.35

4.7

5.7

—

Osteopathies and chondropathies

2.05

1.33

5.4

5.6

—

Other disorders of eye and adnexa

2.50

1.30

3.5

6.2

—

Chronic sinusitis

2.50

1.30

3.0

3.3

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.35

1.29

5.7

4.5

—

Other and unspecified effects of external causes

2.08

1.27

7.4

6.6

—

Adverse effects, not elsewhere classified

2.29

1.26

7.8

7.3

—

Complications of procedures, not elsewhere classified

2.02

1.26

4.5

—

Haemorrhage from respiratory passages

2.25

1.25

3.5

5.9

—

Exposure to other specified factors

109

0.42

1.24

9.0

5.5

—

Abnormal findings on examination of blood, without diagnosis

2.02

1.23

4.4

5.6

—

Hypertension, essential

2.26

1.23

3.3

2.3

—

Weight loss

2.63

1.21

10.2

7.6

—

Abnormalities of gait and mobility

2.63

1.21

3.4

7.3

—

Heterophoria

2.63

1.21

7.6

6.4

—

Pain in throat and chest

1.80

1.19

3.7

4.9

—

Other arthrosis

2.66

1.17

2.4

1.8

—

Codeine

2.17

1.17

2.1

1.9

—

Conjunctivitis (acute, non atopic)

1.87

1.16

6.3

7.5

—

Bacterial sepsis of newborn

2.53

1.15

9.6

7.0

—

Nerve, nerve root and plexus disorders

1.98

1.14

1.6

4.3

—

Chronic periodontitis, including avohilmo

2.03

1.12

1.8

2.6

—

Other functional intestinal disorders

1.76

1.12

5.2

7.6

—

Periodontitis

2.03

1.11

1.8

2.6

—

Atopic dermatitis, strict definition

1.71

1.11

6.7

6.6

—

Disorders of synovium and tendon

2.27

1.10

4.7

4.3

—

Impetigo

2.38

1.09

8.2

7.6

—

Chronic suppurative otitis media, including avohilmo

2.38

1.09

5.8

7.3

—

Undescended testicle

2.39

1.09

8.2

8.3

—

Childhood allergy (age < 16)

1.67

1.07

5.7

7.0

—

Atopic dermatitis

1.66

1.05

6.9

5.9

—

Disorders of gallbladder, biliary tract and pancreas

1.84

1.05

4.6

3.8

—

Ulcerative colitis, NAS

2.27

1.03

7.4

5.6

—

Delivery, wide proxy

0.00

1.03

0.0

3.3

—

Single spontaneous delivery

0.00

1.03

0.0

3.1

—

Other symptoms and signs involving cognitive functions and awareness

2.28

1.02

1.8

3.9

—

Polyarthropathies

1.77

1.01

4.4

5.9

—

Delivery

0.00

1.01

0.0

3.0

—

Finngen Rheumatological endpoints

1.64

1.01

4.4

5.6

—

Other and unspecified urticaria

2.00

1.00

8.9

6.8

—

Other retinal disorders

2.02

0.99

3.6

3.7

—

Other joint disorders

0.54

0.98

5.4

5.7

—

Any death

2.39

0.97

1.0

3.3

—

Reimbursement for rheumatic diseases

1.79

0.96

3.7

6.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.76

0.94

2.6

7.2

—

Congenital malformations of genital organs

1.88

0.93

8.0

8.8

—

Cutaneous abscess, furuncle and carbuncle

2.07

0.89

6.2

5.2

—

Other arthritis (FG)

2.07

0.89

5.7

5.2

—

Non-rheumatic valve diseases

1.86

0.87

4.5

5.9

—

Allergic colitis

2.00

0.87

11.3

8.2

—

Hypothyroidism, strict autoimmune

1.81

0.85

3.0

4.6

—

Keratitis

1.94

0.84

2.5

5.2

—

Any event in cancer register

1.58

0.80

2.7

6.2

—

Mental retardation, wide definition

1.69

0.80

7.4

9.0

—

Mental retardation

1.69

0.80

7.4

9.0

—

Desensitization to allergens

0.00

0.78

0.0

7.5

—

Redundant prepuce, phimosis and paraphimosis

1.80

0.78

3.8

6.4

—

Contact with and exposure to communicable diseases

1.61

0.77

7.2

6.9

—

Infections specific to the perinatal period

1.77

0.76

9.3

7.9

—

Erysipelas

2.12

0.75

3.0

2.1

—

Valvular heart disease excluding rheumatic fever

1.67

0.74

7.7

6.3

—

Non-allergic asthma

2.08

0.74

5.8

9.5

—

Diseases of male genital organs

1.50

0.74

6.3

6.8

—

Other disorders of penis

2.00

0.72

10.6

8.2

—

Type 2 diabetes, strict (exclude DM1)

1.71

0.69

1.9

1.7

—

Type 2 diabetes, definitions combined

1.71

0.69

1.9

1.7

—

Depression or dysthymia

1.68

0.68

4.6

3.4

—

Migraine

1.57

0.68

3.3

6.5

—

Other soft tissue disorders, not elsewhere classified

1.41

0.68

4.5

6.2

—

Recurrent or chronic depression

1.85

0.67

1.4

2.8

—

Diseases of arteries, arterioles and capillaries

1.85

0.67

2.6

3.6

—

Inflammatory diseases of female pelvic organs

1.84

0.67

1.2

3.1

—

Superficial injury of ankle and foot

1.79

0.66

9.4

7.0

—

Other antidepressants

1.55

0.65

2.8

3.6

—

Chronic apical periodontitis

0.58

0.65

1.0

5.0

—

Neurological diseases

1.36

0.61

5.1

7.3

—

Injury, poisoning and certain other consequences of external causes

1.47

0.61

7.1

7.0

—

Ulcerative colitis

1.67

0.61

7.4

5.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.59

0.61

4.5

5.7

—

Disorders of choroid and retina

1.58

0.61

3.3

3.6

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.52

0.58

9.1

7.9

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.51

0.58

9.1

7.9

—

Autism spe

0.00

0.58

0.0

6.7

—

Cerebrovascular diseases

1.69

0.57

3.8

3.4

—

Caries of dentine, including avohilmo

1.45

0.57

7.4

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1.67

0.56

3.3

5.1

—

Solid cancers, helper endpoint

1.44

0.52

3.6

5.8

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.50

0.51

10.2

5.3

—

Inflammatory bowel disease

1.50

0.51

6.3

5.4

—

Asthma (diagnoses ohter than nonallergic)

104

1.36

0.51

5.3

6.1

—

Type 2 diabetes, definitions combined, including avohilmo

1.57

0.50

1.9

2.0

—

Injuries to the shoulder and upper arm

0.65

0.49

3.7

5.3

—

Other (not insulin) diabetes medications

1.54

0.49

1.9

2.0

—

Allergic conjunctivitis

0.59

0.45

4.0

6.4

—

Injuries to the ankle and foot

1.35

0.45

6.5

5.6

—

Focal epilepsy

1.37

0.44

5.9

6.5

—

Antenatal screening

0.00

0.43

0.0

1.7

—

Fracture of foot, except ankle

1.61

0.43

5.4

5.9

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.61

0.43

5.6

9.3

—

Angina pectoris

0.00

0.42

0.0

1.4

—

Myocardial infarction

0.00

0.42

0.0

2.0

—

False labour

0.00

0.42

0.0

2.7

—

Diseases of oesophagus, stomach and duodenum

1.34

0.41

2.7

6.1

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.41

0.0

7.4

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.41

0.0

7.8

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.52

0.41

3.0

6.6

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.41

0.0

4.3

—

Injuries to unspecified part of trunk, limb or body region

0.00

0.41

0.0

6.7

—

Peritonsillar abscess

0.00

0.40

0.0

3.8

—

Dental pulpitis, including avohilmo

0.66

0.40

1.7

4.7

—

Soft tissue disorders

1.26

0.40

5.4

6.2

—

Asthma/COPD (KELA code 203)

1.29

0.40

4.9

5.9

—

External causes of morbidity and mortality

1.31

0.39

6.0

6.5

—

Type of accident

1.35

0.37

11.2

5.4

—

Exposure to unspecified factor

114

0.76

0.36

3.8

6.2

—

Injuries to the hip and thigh

1.39

0.35

4.8

5.6

—

Migraine without aura

1.40

0.35

3.7

6.2

—

Disorders of lipoprotein metabolism and other lipidaemias

1.33

0.33

2.7

3.5

—

Mood [affective] disorders

1.30

0.33

3.1

4.8

—

Mood disorders

1.29

0.33

3.1

4.8

—

Other congenital malformations

1.28

0.32

6.5

8.5

—

Type 2 diabetes

1.36

0.32

1.9

2.5

—

Triptan medication for migraine, single purchase ok

0.69

0.31

3.6

5.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

0.69

0.31

3.6

5.1

—

Mycoses

1.30

0.31

6.3

4.9

—

D07AA Corticosteroids, weak (group I)

1.32

0.30

5.6

7.9

—

Other specific joint derangements/joint disorders

0.75

0.29

4.0

5.6

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.24

0.29

11.1

8.4

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.32

0.28

3.0

4.1

—

Depression

1.28

0.28

3.3

4.9

—

Codeine or tramadol medication

1.29

0.28

2.1

1.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.28

0.28

3.4

3.6

—

Diabetes, insulin treatment (Kela reimbursement)

0.77

0.28

2.0

5.9

—

Chronic lower respiratory diseases

1.20

0.28

5.2

5.9

—

Behavioural syndromes associated with physiological disturbances and physical factors

0.77

0.28

3.4

5.0

—

Congenital malformations of cardiac septa

1.27

0.27

6.8

8.4

—

Other nutritional deficiencies

1.23

0.27

3.0

5.6

—

Transport accidents

1.23

0.27

6.9

5.7

—

Epilepsy

1.21

0.26

5.3

7.5

—

Parasetamol

1.27

0.26

3.8

5.7

—

Benzodiazepine use

1.26

0.26

1.9

3.7

—

Falls/tendency to fall

0.83

0.25

5.5

6.1

—

Use of hypnotics and sedatives

1.29

0.25

2.2

5.1

—

Disorders of conjunctiva

106

1.21

0.25

5.4

6.0

—

Asthma, including avohilmo

100

1.18

0.24

5.4

5.9

—

Injuries to the head

104

1.18

0.24

5.3

6.0

—

Infections with a predominantly sexual mode of transmission

1.26

0.22

1.6

3.5

—

Conjunctivitis

104

1.20

0.22

5.7

6.1

—

Unspecified fall

0.76

0.22

6.1

6.7

—

Intracranial injury

0.74

0.22

4.6

6.2

—

Exclusions for E4_PCOS_CONSORTIUM

1.22

0.22

7.3

6.6

—

Open wound of head

1.25

0.22

6.5

—

Presence of cardiac and vascular implants and grafts

0.00

0.22

0.0

1.5

—

Prolonged pregnancy

0.00

0.21

0.0

2.6

—

Myocardial infarction, strict

0.00

0.21

0.0

1.4

—

Effects of foreign body entering through natural orifice

1.19

0.21

8.2

5.7

—

Enterobiasis

0.00

0.21

0.0

9.4

—

Major anomalies of jaw size

0.00

0.21

0.0

6.6

—

Exposure to other and unspecified animate mechanical forces

0.00

0.21

0.0

9.9

—

Helminthiases

0.00

0.21

0.0

9.4

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.21

0.0

7.9

—

Anorexia (incl.atypical)

0.00

0.21

0.0

5.3

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.21

0.0

5.4

—

Osteomyelitis

0.00

0.21

0.0

7.7

—

Etanercept

0.00

0.21

0.0

8.8

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.21

0.0

5.7

—

Contact with other sharp object(s)

0.00

0.21

0.0

7.5

—

Superficial injury of shoulder and upper arm

0.00

0.21

0.0

6.2

—

Allergic contact dermatitis

0.00

0.21

0.0

6.2

—

Functional dyspepsia

0.00

0.21

0.0

4.4

—

Benign lipomatous neoplasm

0.00

0.21

0.0

3.1

—

Supervision of normal pregnancy

0.00

0.21

0.0

1.8

—

Other abnormal products of conception

0.00

0.21

0.0

2.3

—

Generalized epilepsy, strict definition

0.00

0.21

0.0

7.8

—

Other eating disorders

0.00

0.21

0.0

5.9

—

Primary gonarthrosis, bilateral

0.00

0.21

0.0

1.4

—

Congenital malformations of great arteries

1.17

0.21

7.0

8.8

—

Foreign body in respiratory tract

0.00

0.21

0.0

6.7

—

Superficial injury of hip and thigh

0.00

0.21

0.0

5.7

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.77

0.20

2.0

6.1

—

Liveborn infants according to place of birth

0.00

0.20

0.0

7.2

—

Bitten or struck by other mammals

0.00

0.20

0.0

5.3

—

Substance use, excluding alcohol

0.00

0.20

0.0

3.6

—

Myalgia

0.00

0.20

0.0

3.7

—

Diabetes medication

0.81

0.19

2.0

6.0

—

Other congenital malformations

1.18

0.19

6.5

8.1

—

Selective serotonin reuptake inhibitors

1.20

0.19

3.4

5.3

—

Episodal and paroxysmal disorders

1.14

0.18

4.2

6.6

—

Obesity

1.14

0.17

2.4

5.5

—

Obesity and other hyperalimentation

1.14

0.17

2.4

5.5

—

Sleep apnoea

0.75

0.17

4.4

3.3

—

Hypothyroidism, other/unspecified

1.14

0.15

3.3

4.4

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.11

0.15

3.3

4.3

—

Disorders of eyelid, lacrimal system and orbit

1.12

0.15

3.7

5.7

—

Intracranial trauma

0.81

0.14

4.1

7.3

—

Dyspnoea

1.18

0.13

3.1

6.2

—

Diabetes mellitus

0.87

0.11

2.4

6.2

—

Diabetes, varying definitions

0.87

0.11

2.4

6.2

—

Hard cardiovascular diseases

0.87

0.10

6.6

5.9

—

Biguanides

1.13

0.10

1.8

1.9

—

Focal epilepsy, strict definition

1.14

0.10

5.8

6.7

—

Other external causes of accidental injury

0.89

0.09

5.2

6.2

—

Insulin, fast-acting

0.83

0.08

1.8

6.9

—

Insulin, fast-acting or short human

0.83

0.08

1.8

6.9

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.07

0.08

5.3

6.0

—

Pain in joint

1.04

0.08

4.4

6.5

—

Septal defects

1.05

0.08

7.6

8.5

—

Haemorrhagic and haematological disorders of fetus and newborn

1.04

0.08

6.3

8.0

—

Fracture of forearm

0.81

0.07

5.8

5.5

—

Lower back pain or/and sciatica

0.86

0.07

1.3

3.6

—

Disorders of the thyroid gland

1.08

0.07

3.3

4.3

—

Insulin medication

0.87

0.07

1.6

6.2

—

Constipation

0.91

0.06

4.4

6.6

—

Dorsalgia

1.09

0.03

2.3

5.0

—

Other dorsopathies, not elsewhere classified

1.08

0.03

2.2

5.0

—

Arthropathies

0.94

0.03

5.8

5.9

—

Major coronary heart disease event

0.95

0.00

6.0

5.9

—

Coronary revascularization (ANGIO or CABG)

0.99

0.00

6.0

—

Emergency coronary revascularization (for ACS)

0.97

0.00

6.0

—

Injuries to the elbow and forearm

1.03

0.00

7.1

5.6

—

Fall on same level

105

0.99

0.00

5.9

5.8

—

Ischemic heart diseases

1.04

0.00

5.6

6.0

—

Percutaneous Coronary Intervention

0.99

0.00

6.0

—

Dorsopathies

1.02

0.00

3.1

6.0

—

Accidents

1.03

0.00

4.7

6.2

—

Congenital aortic valve stenosis

0.00

0.0

10.3

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.0

5.8

—

Other and unspecified injuries of wrist and hand

0.00

0.0

8.2

—

Appendicitis, broad definition

0.96

0.00

4.2

3.3

—

Nontoxic goitre/thyroid nodule

0.00

0.0

1.0

—

Reactive arthropathies, FINNGEN

0.00

0.0

6.2

—

Other disorders of pigmentation

0.00

0.0

6.8

—

Unstable angina pectoris

0.00

0.0

1.6

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.0

2.8

—

Fibroblastic disorders

0.00

0.0

1.8

—

Malignant neoplasm of breast, HER2-negative

0.00

0.0

1.0

—

Spondylolisthesis/Spondylolysis

0.00

0.0

5.2

—

Mental disorders, not otherwise specified

0.00

0.0

5.5

—

Heartburn

0.00

0.0

3.8

—

Injury of muscle and tendon at hip and thigh level

0.00

0.0

5.7

—

Nasal polyp

0.00

0.0

2.4

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.0

4.4

—

Recurrent dislocation and subluxation of joint

0.00

0.0

3.3

—

Medicines for HER+ breast cancer

0.00

-0.00

0.0

1.1

—

Concussion

0.96

-0.00

4.1

7.3

—

Diseases of appendix

0.96

-0.00

4.2

3.3

—

Toxic effect of contact with venomous animals

0.00

-0.00

0.0

7.2

—

Contusion of toe(s) without damage to nail

0.00

-0.00

0.0

7.0

—

Foreign body in alimentary tract

0.00

-0.00

0.0

6.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

0.98

-0.00

1.6

6.5

—

Injury of unspecified body region

0.00

-0.00

0.0

7.3

—

Open wound of forearm

0.00

-0.00

0.0

5.1

—

Injury of muscle and tendon at wrist and hand level

0.00

-0.00

0.0

4.8

—

Myocardial infarction, without ST-elevation

0.00

-0.00

0.0

1.6

—

Other and unspecified injuries of head

0.00

-0.00

0.0

7.8

—

Primary open-angle glaucoma, strict

0.00

-0.00

0.0

1.8

—

Contact with sharp glass

0.00

-0.00

0.0

6.5

—

Stenosis and insufficiency of lacrimal passages

0.00

-0.00

0.0

7.0

—

Intentional self-harm by sharp object

0.00

-0.00

0.0

5.6

—

Struck by thrown, projected or falling objec

0.00

-0.00

0.0

6.5

—

Autism spe, excluding more controls

0.00

-0.00

0.0

7.7

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

5.2

—

Obesity due to excess calories

1.00

-0.00

2.0

5.7

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

-0.00

0.0

2.8

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

-0.00

0.0

5.8

—

Fall involving bed

0.00

-0.00

0.0

9.8

—

Outcome of delivery

0.00

-0.00

0.0

1.4

—

Muscular dystrophy

0.00

-0.00

0.0

7.8

—

Insulin, intermediate and long-acting

0.94

-0.00

1.0

6.5

—

Primary open-angle glaucoma

0.00

-0.00

0.0

1.8

—

Optic atrophy

0.00

-0.00

0.0

9.0

—

Postpartum care and examination

0.00

-0.00

0.0

1.4

—

AV-block

0.00

-0.00

0.0

5.8

—

Unspecified visual impairment (binocular)

0.00

-0.00

0.0

7.3

—

Optic atrophy

0.00

-0.00

0.0

9.0

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

-0.00

0.0

3.3

—

Polycystic ovarian syndrome, broad definition

0.00

-0.00

0.0

2.0

—

Varicose veins of other sites

0.00

-0.00

0.0

4.6

—

Other disorders of breast

0.00

-0.00

0.0

2.0

—

Gastro-oesophageal reflux disease

0.94

-0.00

3.5

6.0

—

Other sleep disorders

0.00

-0.00

0.0

4.6

—

Constitutional tall stature

0.00

-0.00

0.0

6.2

—

Gender identity disorders

0.00

-0.00

0.0

5.7

—

Protein-energy malnutrition of moderate and mild degree

0.00

-0.00

0.0

10.6

—

Disorder of the sleep-wake schedule

0.00

-0.00

0.0

9.6

—

severe traumatic brain injury, does not include concussion

0.00

-0.00

0.0

5.8

—

Other disorders of veins

0.00

-0.00

0.0

1.6

—

Dermatophytosis

0.88

-0.00

4.2

4.8

—

Crohn disease (strict definition, require KELA)

0.00

-0.00

0.0

5.8

—

Malignant neoplasm of bone and articular cartilage

0.00

-0.00

0.0

7.8

—

Maltreatment syndromes

0.00

-0.00

0.0

6.4

—

Benign neoplasm of brain and other parts of central nervous system

0.00

-0.00

0.0

6.3

—

Postpartum haemorrhage due to retained placenta

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of adrenal gland, including Hilmo

0.00

-0.00

0.0

8.6

—

Bicuspidal aortic valve syndrome

0.00

-0.00

0.0

7.2

—

Preterm labour and delivery

0.00

-0.00

0.0

1.2

—

Other congenital malformations of skull and face bones

0.00

-0.00

0.0

8.7

—

Maternal care for other conditions predominantly related to pregnancy

0.00

-0.00

0.0

2.0

—

Other/unspecified reactive arthropathies

0.00

-0.00

0.0

6.3

—

Maternal care for known or suspected malpresentation of fetus

0.00

-0.00

0.0

2.0

—

Familial hypercholesterolemia

0.00

-0.00

0.0

6.2

—

1.00

-0.00

2.8

3.1

—

Impingement syndrome of shoulder

0.00

-0.00

0.0

1.6

—

Dermatitis due to ingested food

0.96

-0.00

7.6

7.9

—

Reactive arthropathies

0.00

-0.00

0.0

7.2

—

Perineal laceration during delivery

0.00

-0.00

0.0

3.3

—

Other chromosome abnormalities, not elsewhere classified

0.00

-0.00

0.0

10.8

—

Inflammatory diseases of prostate (prostatitis)

0.00

-0.00

0.0

2.7

—

Haemorrhage in early pregnancy

0.00

-0.00

0.0

1.8

—

Malignant neoplasm of breast

0.00

-0.00

0.0

1.0

—

Low back pain

0.98

-0.00

1.3

4.1

—

Flat foot [pes planus] (acquired)

0.00

-0.00

0.0

5.4

—

Ectopic pregnancy

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.00

-0.00

0.0

1.0

—

Fracture of lower leg, including ankle

0.84

-0.00

4.4

5.0

—

Fracture of shoulder and upper arm

0.89

-0.00

4.8

6.4

—

Assault by bodily force

0.00

-0.00

0.0

3.6

—

Hallux valgus (acquired)

0.00

-0.00

0.0

1.8

—

Premature rupture of membranes

0.00

-0.00

0.0

1.9

—

Down's syndrome

0.00

-0.00

0.0

6.5

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

2.2

—

0.00

-0.00

0.0

8.3

—

Other perinatal haematological disorders

0.00

-0.00

0.0

7.4

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

-0.00

0.0

2.5

—

Seronegative juvenile rheumatoid arthritis

0.00

-0.00

0.0

8.9

—

Poor fetal growth

0.00

-0.00

0.0

1.8

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

10.6

—

Visual field defects

0.00

-0.00

0.0

6.8

—

Use of pramipexole

0.00

-0.00

0.0

3.6

—

L04AC Interleukin inhibitors

0.00

-0.00

0.0

6.2

—

Other diseases of liver

0.00

-0.00

0.0

4.9

—

Alopecia areata

0.00

-0.00

0.0

9.6

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

-0.00

0.0

9.3

—

Benign neoplasm: Colon, unspecified

0.00

-0.00

0.0

1.8

—

Maxillary prognathism

0.00

-0.00

0.0

7.2

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

6.6

—

Medical treatment for female infertility

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS